INTUITIVE SURGICAL INCInsider Trading & SEC Form 4 Analysis
Institutional analysis of internal capital flows based on SEC Form 4 filings.
-$9.4M
Buys minus sales2026.06.12
Latest Form 419
Reporting entitiesNo buyer detected
No open-market buysJeddi Iman
$2.4MAutomated_Intelligence_Report :: ISRG
Algorithmic analysis of recent insider trading activity for ISRG reveals a bearish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 19 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $40.88M.
Market dynamics show a negative net capital flow of $9.42M when isolating open-market purchases versus open-market sales. The trading volume is heavily weighted towards open-market executions, providing a clearer signal of insider conviction regarding current valuation levels compared to option-based equity grants.
From a microstructural perspective, the most significant liquidity event was a divestment by Jeddi Iman (Officer/Other), which accounts for a major share of the recent outflow. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of ISRG.
$40.88M
USD NOMINAL VALUE19
UNIQUE C-SUITE ENTITIES2026.06.12
ISO_8601 FORMATAutomated_Queries :: Frequently Asked Questions
>When was the latest SEC Form 4 filed for ISRG?
The most recent insider transaction on record was filed on 2026.06.12. InsiderAlpha monitors EDGAR filings and updates this terminal as new Form 4 documents are published.
>How many corporate insiders are active in ISRG?
Our dataset currently tracks 19 distinct insiders with reported transactions for ISRG in the active reporting window.
>Is insider buying outweighing selling at ISRG?
Open-market selling volume ($9.42M) currently exceeds buying volume ($0.00M), indicating net liquidation by insiders.